Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COSENSE-1: Tumouroid-guided Chemotherapy Selection in Metastatic Colorectal Cancer
NCT06907342Phase 2Recruiting
- Sponsor
- St. Olavs University Hospital
- Start
- May 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of FOLFOX, FOLFIRI in metastatic colorectal cancer (mCRC), sponsored by St. Olavs University Hospital. Started May 2025; status: recruiting.
02
Drugs
FOLFOXFOLFIRI
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT06907342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907342.